Clinical Trial Update: An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain [Phase 3]

View source ↗

Summary

Open-label long-term Phase 3 trial of pregabalin for central neuropathic pain due to spinal cord conditions completed; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Pain
• Spinal Cord Diseases
• Spinal Cord Injuries

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Spinal Cord Diseases, Spinal Cord Injuries | Phase 3 | Status: COMPLETED | Results posted: 2013-05-17